Skip to main content
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM Journals
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mSphere
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Research and News from ASM Journals
    • mSphere of Influence: Commentaries from Early Career Microbiologists
    • Archive
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Getting Started
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mSphere
    • Editor in Chief
    • Board of Editors
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Applied and Environmental Science

Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes

Dae-Wi Kim, Cung Nawl Thawng, Sang Hee Lee, Chang-Jun Cha
Ana Cristina Gales, Editor
Dae-Wi Kim
aDepartment of Systems Biotechnology and Center for Antibiotic Resistome, Chung-Ang University, Anseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cung Nawl Thawng
aDepartment of Systems Biotechnology and Center for Antibiotic Resistome, Chung-Ang University, Anseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sang Hee Lee
bDepartment of Biological Sciences, National Leading Research Laboratory of Drug Resistance Proteomics, Myongji University, Yongin, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sang Hee Lee
Chang-Jun Cha
aDepartment of Systems Biotechnology and Center for Antibiotic Resistome, Chung-Ang University, Anseong, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Cristina Gales
Escola Paulista de Medicina, Universidade Federal de São Paulo
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mSphere.00203-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

A highly fluoroquinolone-resistant isolate of Aeromonas species was isolated from a wastewater treatment plant and found to possess multiple resistance mechanisms, including mutations in gyrA and parC, efflux pumps, and plasmid-mediated quinolone resistance (PMQR) genes. Complete sequencing of the IncU-type plasmid, pAC3, present in the strain revealed a circular plasmid DNA 15,872 bp long containing two PMQR genes [qnrS2 and aac(6′)-Ib-cr]. A mobile insertion cassette element containing the qnrS2 gene and a typical miniature inverted-repeat transposable element (MITE) structure was identified in the plasmid. The present study revealed that this MITE sequence appears in other Aeromonas species plasmids and chromosomes. Plasmid pAC3 was introduced into Escherichia coli, and its PMQR genes were expressed, resulting in the acquisition of resistance. Proteome analysis of the recipient E. coli strain harboring the plasmid revealed that aac(6′)-Ib-cr expression was constitutive and that qnrS2 expression was dependent upon fluoroquinolone stress through regulation by regulator of sigma D (Rsd). To the best of our knowledge, this is the first report to characterize a novel MITE sequence upstream of the PMQR gene within a mobile insertion cassette, as well as the regulation of qnrS2 expression. Our results suggest that this mobile element may play an important role in qnrS2 dissemination.

IMPORTANCE In the present study, plasmid pAC3 isolated from a highly fluoroquinolone-resistant isolate of Aeromonas species was sequenced and found to contain two fluoroquinolone resistance genes, aac(6′)-Ib-cr and qnrS2. Comparative analyses of plasmid pAC3 and other Aeromonas sp. IncU-type plasmids revealed a mobile insertion cassette element with a unique structure containing a qnrS2 gene and a typical miniature inverted-repeat transposable element (MITE) structure. This study also revealed that this MITE sequence appears in other Aeromonas species plasmids and chromosomes. Our results also demonstrate that the fluoroquinolone-dependent expression of qnrS2 is associated with rsd in E. coli DH5α harboring plasmid pAC3. Our findings suggest that the mobile element may play an important role in qnrS2 dissemination and that Aeromonas species constitute an important reservoir of fluoroquinolone resistance determinants in the environment.

INTRODUCTION

Fluoroquinolones are broad-spectrum antimicrobial agents that have been widely used to treat bacterial infections (1). Residual fluoroquinolones have been detected at various environmental sites (2), including wastewater treatment plants (WWTPs) (3), where antibiotics may act as a selective pressure that allows a potential genetic exchange of resistance genes (4, 5).

Bacterial resistance to fluoroquinolones has been demonstrated to be caused by (i) chromosomal mutations in the genes encoding target proteins such as DNA gyrase or topoisomerase IV (6), (ii) efflux pumps (7), (iii) Qnr family proteins (8), and (iv) inactivation by fluoroquinolone N-acetyltransferase AAC(6′)-Ib-cr (9). Plasmid-mediated quinolone resistance (PMQR) is known to involve aac(6′)-Ib-cr, qnr family genes, and genes encoding efflux pumps (qepA and oqxAB) (10). The prevalence of qnr and aac(6′)-Ib-cr genes in plasmids of clinical and environmental isolates has been reported worldwide, including in Korea (11, 12). Qnr family proteins interact with their target proteins, thus blocking the action of fluoroquinolones and reducing their inhibitory effect (8). AAC(6′)-Ib-cr is an aminoglycoside acetyltransferase variant with two amino acid substitutions (W102R and D179Y) that confer extended substrate specificity for fluoroquinolones, thus leading to resistance (9).

Members of the genus Aeromonas are known to be autochthonous to aquatic environments, although they have been isolated from a wide variety of habitats (13). Some Aeromonas species have been recognized as opportunistic human pathogens, as well as primary fish pathogens (13); these species exhibited multidrug resistance, including to fluoroquinolones (14–16). The presence of quinolone resistance determinants has been reported in various Aeromonas spp.; several strains contain multiple resistance mechanisms, including mutations at quinolone resistance-determining regions (QRDRs) (17–21), efflux pumps (18, 21, 22), and PMQR genes (23–26). In some Aeromonas sp. plasmids, aac(6′)-Ib-cr and qnrS2 are colocalized with other resistance genes (26–28). Comparative analysis of IncU-type plasmids from Aeromonas spp. revealed the conservation of PMQR genes, as well as high genetic plasticity in the region of PMQR genes (26).

In this study, Aeromonas sp. strain C3, which displays high-level fluoroquinolone resistance, was isolated from a WWTP and the multiple resistance mechanisms, including PMQR, were characterized in this strain. Comparative analysis of the plasmid from strain C3 revealed a novel mobile insertion cassette element (MICE) related to transposition. The role of the plasmid and the regulation of PMQR in a recipient Escherichia coli strain were elucidated by proteome analysis.

RESULTS

Isolation and identification of a bacterium with high-level fluoroquinolone resistance.A bacterial strain isolated from a WWTP displayed unusually high-level resistance to various fluoroquinolones (Table 1). The strain was able to transform fluoroquinolones to their N-acetylated metabolites, which were structurally identified by liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and proton nuclear magnetic resonance (NMR) analyses (see Tables S1 and S2) (29). On the basis of its 16S rRNA gene sequence, the isolate showed 99.9% similarity with Aeromonas hydrophila subsp. hydrophila ATCC 7966T. We therefore designated the isolate Aeromonas sp. strain C3.

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

Fluoroquinolone susceptibilities and N-acetylation activities of Aeromonas sp. strain C3, E. coli DH5α, and E. coli(pAC3)

TABLE S1

LC-MS/MS analysis of fluoroquinolones and their N-acetylated metabolites. Download TABLE S1, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

TABLE S2

Proton NMR spectral parameters of ciprofloxacin and N-acetyl ciprofloxacin. Multiplicities are abbreviated as follows: s, singlet; d, doublet; m, multiplet. Download TABLE S2, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

The presence of multiple fluoroquinolone resistance mechanisms in strain C3.To elucidate this high-level quinolone resistance, the resistance determinants present in the strain were characterized. QRDR sequence analysis showed that point mutations related to resistance were found in the QRDRs of GyrA (D87N) and ParC (S80I). Considering the MICs of Aeromonas spp. harboring these mutations (20), the extremely high level of fluoroquinolone resistance exhibited by strain C3 suggested the presence of additional resistance mechanisms. Of the PMQR genes tested, only aac(6′)-Ib-cr and qnrS were detected by PCR; these two genes were found to be located in plasmid pAC3 of the strain. The fluoroquinolone resistance of strain C3 was also examined by monitoring changes in MICs in the presence of the efflux pump inhibitors PAβN and NMP, which are known to inhibit a broad range of efflux pumps (30, 31). NMP caused a significant reduction (4- to 16-fold) in the MICs of all of the fluoroquinolones tested (Table 1), while PAβN resulted in minor effects on the MICs of enrofloxacin, sarafloxacin, and pefloxacin.

Comparative analysis of plasmid pAC3.The plasmid harboring the PMQR genes, designated pAC3, was isolated, sequenced, and annotated. The total length of the complete plasmid sequence is 15,872 bp and includes 21 protein-coding genes (Fig. 1A). The plasmid was identified as a member of the IncU-type plasmid family and contained two PMQR genes, aac(6′)-Ib-cr and qnrS2 (Fig. 1A). For comparative plasmid analyses, the six IncU-type plasmids phylogenetically closest to plasmid pAC3 were selected (see Fig. S1 in the supplemental material) and local colinear block (LCB) analysis was performed with MAUVE software (see Fig. S1). Plasmid pAC3 exhibited the closest relationship with plasmids pAH6 and pP2G1, which possess the identical PMQR genes (Fig. 1A). These plasmids have the same backbone structure, from the replication gene rep to the metallopeptidase gene mpR (Fig. 1A) (26).

FIG S1

Phylogenetic and LCB analyses of IncU-type plasmids. The phylogenetic tree shown was constructed with MEGA 6.0, and LCB analysis was performed with MAUVE software. IncU-type plasmids, including pAC3, pAH6, pP2G1, pRA3, pFBAOT6, pAH227, and pASCH21, were used for analyses. IncQ-type plasmid pRAS3.1 was used as an outgroup. Download FIG S1, PDF file, 0.4 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Comparative analysis of Aeromonas sp. IncU-type plasmids and the MICE of plasmid pAC3 containing a MITE. (A) Plasmids pAH6 and pP2G1 were used for comparative analysis with plasmid pAC3. Shaded connections between the plasmids show the conserved and shared regions (>99% identity). The red box and arrow indicate the MICE and the MITE, respectively. (B) Genetic map of the MICE region carrying the MITE sequence in plasmid pAC3. IRR, right inverted repeat; IRL, left inverted repeat.

A MICE bracketed by 22-bp left and right inverted repeats was found to contain the qnrS2 gene. Insertion of the MICE disrupted the mpR gene encoding a putative zinc metalloprotease. IncU plasmids carrying the qnrS2 gene from other Aeromonas spp. have been found in Europe and Asia (26–28). The presence of the qnrS2-carrying MICE structure in different Aeromonas species from geographically distant aquatic environments suggests that this PMQR determinant is widespread in this genus, and these MICE-type structures are potential vehicles of PMQR determinants (32). Interestingly, a novel genetic structure not present in other MICE structures found in Aeromonas species (26–28) was discovered inside the MICE of plasmid pAC3 and exhibited a typical miniature inverted-repeat transposable element (MITE) structure (33, 34). The MITE consists of a 75-bp core sequence bracketed by 4-bp direct repeats (DRs) and 17-bp terminal inverted repeats (TIRs) (Fig. 1B). Both the MICE and the MITE are nonautonomous derivatives of insertion sequences generated by internal deletion, and the difference between these two elements is the presence of coding sequences (CDSs) (35). In the present study, the MICE harbored the qnrS2 gene while the MITE carried no passenger gene.

MITE sequences have not been previously identified in Aeromonas species. The present study revealed that these sequences are also present in the partial fragment sequence of plasmid p42 from A. media A39 (24); pGNB2 from an uncultured bacterium (36); and the chromosomes of A. media WS, A. veronii AVNIH1, and A. hydrophila GYK1. The MITE of plasmid p42 is identical to that of plasmid pAC3; in contrast to plasmid pAC3, in IncQ-type plasmid pGNB2, the MITE is found upstream of the qnrS2 gene (Fig. 2A). The MITE sequences were also frequently found in the genome of A. media WS (Fig. 2B). All of these MITE sequences were highly conserved, except for the DRs (see Fig. S2).

FIG S2

Alignment of multiple MITE sequences from plasmids pAC3, p42, and pGNB2, as well as the genomes of A. media WS, A. veronii AVNIH1, and A. hydrophila GYK1. Light gray-, dark gray-, and red-shaded sequences indicate 4-bp DR, 17-bp TIR, and 75-bp core sequences of the MITE, respectively. Download FIG S2, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Genetic characterization of the MITE-harboring regions in Aeromonas sp. plasmids and chromosomes. (A) Comparison of plasmids p42 and pGNB2 with plasmid pAC3. Shaded connections between the plasmids show the conserved and shared regions. (B) Genetic map of regions containing MITE sequences in Aeromonas sp. chromosomes. White arrowheads indicate gene truncations; the transposase-, integrase-, and hypothetical-protein-encoding genes are tnp, int, and hyp, respectively.

The role of PMQR proteins in fluoroquinolone resistance.Introduction of PMQR into other bacteria poses a potential risk of dissemination of antibiotic resistance. Plasmid pAC3 was successfully introduced into antibiotic-susceptible E. coli DH5α. Transformants cultured in the presence of fluoroquinolones showed the production of N-acetylated fluoroquinolones. To further elucidate the resistance mechanisms of PMQR, an antibiotic susceptibility test and an N-acetylation activity assay against five different fluoroquinolones were performed with Aeromonas sp. strain C3, parental E. coli DH5α, and E. coli DH5α harboring plasmid pAC3 [E. coli(pAC3)]. The results demonstrate that E. coli(pAC3) acquired resistance to all of the fluoroquinolones tested (Table 1). Similar to that from strain C3, the cell-free protein extract from E. coli(pAC3) was also able to transform norfloxacin, ciprofloxacin, and sarafloxacin into their N-acetylated metabolites (Table 1). No activity was detected with enrofloxacin and pefloxacin, which are structurally inaccessible to AAC(6′)-Ib-cr. The acetyltransferase activity present in E. coli(pAC3) suggests that the introduced resistance was conferred by AAC(6′)-Ib-cr. Interestingly, the MICs of enrofloxacin and pefloxacin for E. coli(pAC3) increased significantly, although acetyltransferase activity was not detected with these substrates. These results imply that qnrS2, which is also located on the plasmid, contributes to resistance.

Expression of PMQR proteins.To further confirm the role of the PMQR of plasmid pAC3, the expression of AAC(6′)-Ib-cr and QnrS2 was analyzed by a proteomics approach. Proteomes were analyzed by using cells spiked at mid-exponential phase with fluoroquinolones at concentrations based on the MICs (see Table S3). The numbers of proteins detected by proteome analysis are detailed in Table S3. Proteomes obtained from strain C3, E. coli DH5α, and E. coli(pAC3) cells treated with ciprofloxacin (at the MIC) and enrofloxacin (two or three times the MIC) were compared with those of untreated cells. AAC(6′)-Ib-cr was found to be constitutively expressed in both strain C3 and E. coli(pAC3) regardless of fluoroquinolone treatment and the host cell (Fig. 3A). The level of AAC(6′)-Ib-cr expression in strain C3 was 3- to 4-fold higher than that in E. coli(pAC3) (Fig. 3A). These results coincide with the higher N-acetylation activities of the cell-free protein extract from strain C3 than that from E. coli(pAC3) (Table 1). QnrS2 was expressed in E. coli(pAC3) when the cells were treated with fluoroquinolones (Fig. 3B). These results explain why E. coli(pAC3) acquired resistance to enrofloxacin and pefloxacin (Table 1). In contrast, QnrS2 expression was not detected in strain C3 under the conditions used (Fig. 3B); QnrS2 was not expressed, even under higher concentrations of fluoroquinolone treatment (up to 16 and 32 times the MIC), suggesting that it may not be significantly involved in fluoroquinolone resistance in the Aeromonas strain.

TABLE S3

Summary of proteome results. Download TABLE S3, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

FIG 3
  • Open in new tab
  • Download powerpoint
FIG 3

Expression of AAC(6′)-Ib-cr (A) and QnrS2 (B) in Aeromonas sp. strain C3 and E. coli(pAC3). C, 1×, 2×, and 3× indicate 0-, 1-, 2-, and 3-fold MIC fluoroquinolone treatments, respectively. Protein expression levels are expressed as normalized peptide spectrum matches (PSMs).

The role of plasmid pAC3 in recipient cells in response to fluoroquinolone.A global proteome analysis revealed that a fluoroquinolone target protein (GyrA) was upregulated in response to antibiotic treatment in E. coli DH5α and to a lesser degree in E. coli(pAC3) (see Fig. S3), suggesting that the presence of the plasmid might affect GyrA expression. In addition, expression of AcnB, which is known to be involved in cellular death induced by bactericidal antibiotics (37), increased in response to fluoroquinolone treatment in E. coli DH5α but remained relatively constant in E. coli(pAC3) (see Fig. S3). The expression of several major regulators, including AcrA, IhfA, Crp, HNS, and LRP, decreased in response to fluoroquinolone treatment in E. coli DH5α and to a lesser extent in E. coli(pAC3) (see Fig. S3). These results suggest that the presence of the plasmid in recipient cells may contribute to the reduction of antibiotic stress.

FIG S3

Expression of fluoroquinolone-induced proteins (A) and major regulators (B) in E. coli DH5α and E. coli(pAC3) in response to fluoroquinolone treatment. C, 1×, and 2× indicate 0-, 1-, and 2-fold MIC fluoroquinolone treatments, respectively. Protein expression levels are expressed as normalized peptide spectrum matches (PSMs). NrdA, ribonucleoside-diphosphate reductase 1 alpha subunit; NrdB, ribonucleoside-diphosphate reductase 1 beta subunit; RecA, DNA recombination and repair protein; GyrA, DNA gyrase subunit A; AcnB, aconitase B; ArcA, response regulator of two-component regulatory system; IhfA, integration host factor DNA-binding protein; Crp, cyclic-AMP-activated global transcription factor; HNS, global DNA-binding transcriptional dual regulator; LRP, DNA-binding transcriptional dual regulator. Download FIG S3, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

Regulation of QnrS2 expression in recipient cells.While fluoroquinolone treatment increased the expression of QnrS2 in E. coli(pAC3) (Fig. 3B), the expression of ribonucleoside-diphosphate reductase (NrdA and NrdB) also showed a fluoroquinolone-induced increase in both E. coli DH5α and E. coli(pAC3) (see Fig. S3). The expression of SOS response regulator protein RecA did not increase under these conditions (see Fig. S3). It has been previously reported that NrdA and NrdB were upregulated by fluoroquinolone treatment (38) and that their expression was independent of the SOS response (39). Our results also suggest that expression of QnrS2 was induced not by the SOS response but rather by fluoroquinolone-dependent signaling, as previously reported (40–42). In addition to the major regulators examined, the expression of regulator of sigma D (Rsd) also decreased in response to fluoroquinolone in E. coli DH5α (Fig. 4A). However, rsd expression was upregulated in E. coli(pAC3) (Fig. 4A), suggesting that rsd may be associated with QnrS2 expression. The proteome of an E. colirsd deletion mutant harboring pAC3 [E. coli Δrsd(pAC3)] in response to fluoroquinolone was compared with that of E. coli(pAC3). While the expression of AAC(6′)-Ib-cr did not vary greatly, the expression of QnrS2 was significantly lower in E. coli Δrsd(pAC3) than in E. coli(pAC3) when the strains were treated with the same amount of antibiotic stress (twice the MIC) (Fig. 4B). Furthermore, the rsd deletion mutant was much more susceptible than E. coli(pAC3), with approximately 4-fold lower MICs than those of E. coli(pAC3) (Fig. 4C); although its MICs were higher than those of E. coli DH5α (Table 1; Fig. 4C). These results suggest that the rsd gene plays a role in resistance via the regulation of QnrS2 expression.

FIG 4
  • Open in new tab
  • Download powerpoint
FIG 4

Differential expression of Rsd (A) and PMQR (B) proteins in E. coli strains and susceptibility of the strains to various fluoroquinolones (C). White, gray, and black bars indicate E. coli DH5α, E. coli(pAC3), and E. coli Δrsd(pAC3), respectively. C, 1×, and 2× indicate fluoroquinolone treatments at 0-, 1-, and 2 times the MIC, respectively. Protein expression levels are expressed as normalized relative peptide spectrum matches (PSMs). Nor, Cip, Sar, Enr, and Pef indicate norfloxacin, ciprofloxacin, sarafloxacin, and pefloxacin, respectively.

DISCUSSION

Fluoroquinolone-resistant Aeromonas spp. have been identified in both environmental and clinical isolates; in several strains, high-level fluoroquinolone resistance was found to be conferred by multiple resistance mechanisms (16, 18, 23). In the present study, Aeromonas sp. strain C3, which was highly resistant to fluoroquinolones, was isolated from a WWTP and found to possess mutations in gyrA and parC. Efflux pumps were also shown to contribute to resistance, as previously reported in this genus (18, 21, 22). The presence of 10 resistance-nodulation-division efflux systems in the genome of A. hydrophila subsp. hydrophila ATCC 7966 (22, 43) explains the complex changes in resistance to various fluoroquinolones in the presence of efflux inhibitors (Table 1).

Sequencing analysis of plasmid pAC3 present in strain C3 identified two PMQR determinants, qnrS2 and aac(6′)-Ib-cr. Recent comparative analysis studies of Aeromonas sp. plasmids belonging to the same incompatibility group have revealed the conservation and variation in their sequences and genetic structures (26, 44). In the present study, we identified a mobile insertion cassette with a unique structure containing the PMQR gene qnrS2 and a novel MITE structure. MITEs are small, nonautonomous mobile elements broadly dispersed in prokaryotes, although they have been formalized as nonautonomous transposable sequences in plants (34). Bacterial MITE sequences are primarily found in intergenic regions of the chromosome; however, they are also present intragenically (34). In this study, a MITE structure was identified within the MICE inserted in the mpR gene in plasmid pAC3. The MITE sequence also showed typical signatures of TIRs, a target site duplication consisting of DRs and a core sequence lacking a transposase gene. However, in this study we demonstrate a plasmid location for the MITE associated with an antibiotic resistance gene (ARG). There have been only a few reports on ARG-associated MITEs. A special type of MITE, termed an integron mobilization unit, has been identified in the blaGES-5-carrying plasmid of carbapenem-resistant Enterobacter cloacae (45). MITE-flanked integrons carrying ARGs were also revealed in several Acinetobacter strains (46, 47). These studies suggested that MITEs might be associated with the mobilization of ARGs. The MITE structures in the present study are the first characterized in an Aeromonas species (Fig. 2). The frequent occurrence of MITE structures in Aeromonas spp. suggests that they play a role in the evolution of this genus (Fig. 2B). In particular, the MITE sequences in A. media and A. veronii are associated with nearby transposases (Fig. 2B), raising the possibility of transposition.

Comparative analysis of the proteomes of E. coli DH5α and its derivative harboring plasmid pAC3 revealed constitutive expression of AAC(6′)-Ib-cr and fluoroquinolone-dependent expression of QnrS2 in the recipient strain. The proteome results also suggest that the presence of the plasmid in the recipient strain may reduce antibiotic stress through the expression of PMQR proteins, thus influencing the cellular regulatory network. The promoter sequence of aac(6′)-Ib-cr in pAC3 was found to be conserved with those from many other bacteria, indicating that constitutive and host-independent expression of aac(6′)-Ib-cr could be a general feature. Differential expression of QnrS1 has been reported in a fluoroquinolone-sensitive E. coli strain and a fluoroquinolone-resistant E. coli strain harboring a mutated gyrA gene (41). In the present study, rsd in the recipient strain was shown to be involved in antibiotic stress-dependent expression of qnrS2, independent of the SOS response. Although qnrS2 has been identified as a fluoroquinolone resistance determinant in many Aeromonas species (48, 49), there is no direct evidence that the gene is actually expressed in Aeromonas. A previous study has reported that A. allosaccharophila, which also contains the two PMQR determinants [qnrS2 and aac(6′)-Ib-cr] on a plasmid, remained susceptible to quinolones and that these genes might spread silently (27). The putative promoter region of qnrS2 was highly conserved in the plasmids of Aeromonas spp., indicating that these features may be conserved in this genus. It is still unclear whether the regulation system of qnrS2 expression in Aeromonas is functional.

To the best of our knowledge, this is the first report of a novel mobile insertion cassette structure in the PMQR region of an environmental Aeromonas species, suggesting that the mobile element may play an important role in qnrS2 dissemination. The present study also demonstrates that the fluoroquinolone-dependent expression of qnrS2 is associated with rsd in E. coli DH5α harboring plasmid pAC3. Our results suggest that the genus Aeromonas is important as a reservoir of fluoroquinolone resistance determinants in the environment and should be under intensive surveillance for antibiotic resistance.

MATERIALS AND METHODS

Chemicals and media.Ciprofloxacin, norfloxacin, enrofloxacin, phenylalanine arginine β-naphthylamide (PAβN), and 1-(1-naphthylmethyl)-piperazine (NMP) were purchased from Sigma-Aldrich (St. Louis, MO). Pefloxacin and sarafloxacin were obtained from Santa Cruz Biotechnology (Dallas, TX). R2A, Luria-Bertani (LB), and Mueller-Hinton (MH) media were purchased from BD Science (San Jose, CA).

Isolation and identification of the bacterial strain.A sludge sample obtained from a WWTP in Anseong, South Korea, was inoculated onto R2A agar supplemented with 100 mg/liter ciprofloxacin and incubated at 30°C for 48 h to obtain bacteria with high-level fluoroquinolone resistance. The 16S rRNA gene of the isolate was amplified and sequenced with universal primers (27F and 1492R) and identified by using the EzTaxon-e database (http://www.ezbiocloud.net/ ) (50).

Analysis of antimicrobial susceptibility.MICs of fluoroquinolones were determined by the broth microdilution method detailed in the Clinical and Laboratory Standards Institute (CLSI) guidelines (51). Susceptibility of the strain to fluoroquinolones was assessed in the absence or presence of PAβN or NMP (efflux pump inhibitors) as previously described (30, 31).

Characterization of fluoroquinolone resistance genes.The presence of fluoroquinolone resistance genes, including qnrA, qnrB, qnrC, qnrD, qnrS, qnrVC1, qnrVC4, qepA, aac(6′)-Ib-cr, oqxA, and oqxB (49, 52–54), and mutations in the QRDRs of the gyrA, gyrB, and parC genes (17, 18) were verified by PCR amplification and sequencing as previously described (see Table S4).

TABLE S4

PCR primers used in this study. Download TABLE S4, PDF file, 0.1 MB.
Copyright © 2017 Kim et al.

This content is distributed under the terms of the Creative Commons Attribution 4.0 International license .

Enzyme assay.Bacterial strains were cultivated in LB medium at 30°C until cultures reached the mid-exponential growth phase. Cells were harvested 3 h following the addition of ciprofloxacin at a concentration of 20 mg/liter. Cells were harvested and disrupted by sonication in 20 mM Tris-HCl buffer (pH 7.5), and cell debris was removed by filtration (0.2 μm) to obtain cell-free protein extracts. The reaction mixture, consisting of 90 µM fluoroquinolone substrate, 200 µM acetyl coenzyme A, and 50 to 100 µg of protein extract in 500 µl of 50 mM Tris-HCl buffer (pH 7.5), was incubated at 30°C. Samples taken from the reaction mixtures were subjected to high-performance liquid chromatography (HPLC) analysis with an Atlantis dc18 column (4.6 by 250 mm; Waters Corp., Milford, MA) and a Varian ProStar HPLC system (Varian, Inc., Walnut Creek, CA) set at 280 nm in a diode array detector. The mobile phase consisted of a linear gradient of acetonitrile (10 to 95%) containing 0.1% formic acid at a flow rate of 1 ml/min. One enzyme unit was defined as the amount of enzyme required to convert 1 μmol of substrate to its N-acetylated product per minute at 30°C.

Genetic manipulation of E. coli strains.Plasmid pAC3 was introduced into fluoroquinolone-sensitive E. coli strain DH5α by the transformation method (55), and transformants were selected in the presence of norfloxacin (1 mg/liter). Precise deletion-replacement of the rsd gene from E. coli was conducted by the method of Datsenko and Wanner (56) to obtain E. coli Δrsd.

Sequencing and comparative analysis of the plasmid.The plasmid was isolated by the maxipreparation method as previously described (57). The purified plasmid was treated with Plasmid-Safe ATP-Dependent DNase (Epicentre, Madison, WI) to remove chromosomal DNA contaminants. The plasmid DNA was fragmented with dsDNA Fragmentase (NEB, Hitchin, United Kingdom) to make a proper size for library construction. The DNA fragments were processed with the TruSeq DNA sample preparation kit v 2 (Illumina, San Diego, CA) in accordance with the manufacturer’s instructions. The library was quantified with a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA), and the average size of the library was 300 bp. Plasmid pAC3 was sequenced with the Illumina MiSeq platform (Illumina) at Chunlab (Seoul, South Korea). The paired-end sequencing reads generated were assembled with CLC genomics workbench 6.0 (CLC Bio, Boston, MA), and the contigs and PCR-based gap reads were combined with CodonCode aligner 3.7.1 (CodonCode Corp., Centerville, MA). The CDSs were predicted by Glimmer 3.02 (58). For functional annotation, the predicted CDSs were compared to those previously deposited with catalytic families (CatFam), the COG database, NCBI reference sequences (RefSeq), and the SEED subsystem (59–62). Comparison of plasmid pAC3 with Aeromonas sp. plasmids was conducted by phylogenetic and LCB analyses as previously described (see Fig. S1) (44). Plasmids pAH6 and pP2G1 were used for the comparative analysis of IncU-type plasmids. A partial fragment sequence of plasmid p42; the complete sequence of plasmid pGNB2; and the genome sequences of A. media WS, A. veronii AVNIH1, and A. hydrophila GYK1 were used for comparison of transposable elements with plasmid pAC3.

Proteome analysis.Cells of Aeromonas sp. strain C3, E. coli DH5α, and derivative E. coli strains were prepared as described above. Ciprofloxacin and enrofloxacin were added to each strain at the MIC to three times the MIC. Cells were suspended in lysis buffer (50 mM Tris-HCl buffer [pH 7.8], 6 M guanidine hydrochloride, 10 mM dithiothreitol), and cell-free protein extracts were obtained by sonication. The protein samples were reduced, alkylated, and precipitated with dithiothreitol (10 mM), iodoacetamide (100 mM), and trichloroacetic acid (30%, wt/vol), respectively. The dried protein pellets were dissolved in 50 mM ammonium bicarbonate and digested with trypsin (Thermo Scientific, Waltham, MA). The trypsin digests were cleaned up with Sep-Pak C18 columns (Waters Corp., Milford, MA). One microgram of sample in 0.4% acetic acid was loaded onto a linear ion trap mass spectrometer (LTQ Velos; Thermo Scientific) coupled with a nanosprayer (Thermo Scientific) and a nano column (8.5 cm by 75 μm) packed with C18 medium (200 Å Magic; Michrom Bioresources, Auburn, CA) (63). The organic mobile phase consisted of a linear gradient of acetonitrile (5 to 30%) containing 0.1% formic acid for 380 min at a flow rate of 70 μl/min. The mass spectrometer was operated with the following parameters and options: a 2.0-kV nanospray distal voltage, a capillary temperature of 200°C, and full-scan mode (300 to 5,000 Da). MS/MS data were acquired and deconvoluted with Xcalibur 2.1 (Thermo Scientific), and the whole data set was searched with the SEQUEST search algorithm (64) implemented in the Proteome Discoverer 1.3 software (Thermo Scientific). For protein identification, the genome sequences of E. coli K-12 strain MG1655 (accession no. NC_000913 ) and plasmid pAC3 (accession no. KM204147 ) were used as databases. The genome of A. hydrophila subsp. hydrophila ATCC 7966 (accession no. CP000462 ) was used as a reference genome for quantification of the relative abundance of plasmid proteins in strain C3. Filter parameters for peptide identification (medium peptide confidence [ΔCn] of >0.1 and false discovery rate of <5%) and protein identification (more than two peptides per protein) were applied to the spectra searched by SEQUEST. The shared proteome of biological duplicate samples was used for further analysis, and the protein expression level was determined by using normalized spectral counts.

Accession number(s).The nucleotide sequence of plasmid pAC3 was deposited in GenBank (http://www.ncbi.nlm.nih.gov/GenBank ) under accession number KM204147 . The accession numbers of the other plasmid and genome sequences used in the study are as follows: pAH6, KT315927 ; pP2G1, HE616910 ; p42, EU439941 ; pGNB2, DQ460733 ; A. media WS, CP007567 ; A. veronii AVNIH1, CP014774 ; A. hydrophila GYK1, CP016392 .

ACKNOWLEDGMENTS

C.N.T. is grateful for a CAYSS scholarship to Chung-Ang University. This work was supported by the National Research Foundation of Korea (NRF-2013R1A1A2012270), Ministry of Education, Science & Technology, and funded by the Korean Ministry of Environment (MOE) as the Environmental Health Action Program (2016001350004). The authors declare no conflict of interest.

FOOTNOTES

    • Received May 2, 2017.
    • Accepted May 7, 2017.
  • Copyright © 2017 Kim et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license .

REFERENCES

  1. 1.↵
    1. Picó Y,
    2. Andreu V
    . 2007. Fluoroquinolones in soil—risks and challenges. Anal Bioanal Chem387:1287–1299. doi:10.1007/s00216-006-0843-1.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Rutgersson C,
    2. Fick J,
    3. Marathe N,
    4. Kristiansson E,
    5. Janzon A,
    6. Angelin M,
    7. Johansson A,
    8. Shouche Y,
    9. Flach CF,
    10. Larsson DG
    . 2014. Fluoroquinolones and qnr genes in sediment, water, soil, and human fecal flora in an environment polluted by manufacturing discharges. Environ Sci Technol48:7825–7832. doi:10.1021/es501452a.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rodriguez-Mozaz S,
    2. Chamorro S,
    3. Marti E,
    4. Huerta B,
    5. Gros M,
    6. Sànchez-Melsió A,
    7. Borrego CM,
    8. Barceló D,
    9. Balcázar JL
    . 2015. Occurrence of antibiotics and antibiotic resistance genes in hospital and urban wastewaters and their impact on the receiving river. Water Res69:234–242. doi:10.1016/j.watres.2014.11.021.
    OpenUrlCrossRef
  4. 4.↵
    1. Marathe NP,
    2. Regina VR,
    3. Walujkar SA,
    4. Charan SS,
    5. Moore ER,
    6. Larsson DG,
    7. Shouche YS
    . 2013. A treatment plant receiving waste water from multiple bulk drug manufacturers is a reservoir for highly multi-drug resistant integron-bearing bacteria. PLoS One8:e77310. doi:10.1371/journal.pone.0077310.
    OpenUrlCrossRef
  5. 5.↵
    1. Ruiz J,
    2. Pons MJ,
    3. Gomes C
    . 2012. Transferable mechanisms of quinolone resistance. Int J Antimicrob Agents40:196–203. doi:10.1016/j.ijantimicag.2012.02.011.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Aldred KJ,
    2. Kerns RJ,
    3. Osheroff N
    . 2014. Mechanism of quinolone action and resistance. Biochemistry53:1565–1574. doi:10.1021/bi5000564.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Vila J,
    2. Fàbrega A,
    3. Roca I,
    4. Hernández A,
    5. Martínez JL
    . 2011. Efflux pumps as an important mechanism for quinolone resistance. Adv Enzymol Relat Areas Mol Biol77:167–235. doi:10.1002/9780470920541.ch5.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Tran JH,
    2. Jacoby GA
    . 2002. Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A99:5638–5642. doi:10.1073/pnas.082092899.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Robicsek A,
    2. Strahilevitz J,
    3. Jacoby GA,
    4. Macielag M,
    5. Abbanat D,
    6. Park CH,
    7. Bush K,
    8. Hooper DC
    . 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med12:83–88. doi:10.1038/nm1347.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Jacoby GA,
    2. Strahilevitz J,
    3. Hooper DC
    . 2014. Plasmid-mediated quinolone resistance. Microbiol Spectr2:1–42. doi:10.1128/microbiolspec.PLAS-0006-2013.
    OpenUrlCrossRef
  11. 11.↵
    1. Strahilevitz J,
    2. Jacoby GA,
    3. Hooper DC,
    4. Robicsek A
    . 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev22:664–689. doi:10.1128/CMR.00016-09.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Kim HB,
    2. Park CH,
    3. Kim CJ,
    4. Kim EC,
    5. Jacoby GA,
    6. Hooper DC
    . 2009. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother53:639–645. doi:10.1128/AAC.01051-08.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Janda JM,
    2. Abbott SL
    . 2010. The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev23:35–73. doi:10.1128/CMR.00039-09.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Ko WC,
    2. Yu KW,
    3. Liu CY,
    4. Huang CT,
    5. Leu HS,
    6. Chuang YC
    . 1996. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother40:1260–1262.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Goñi-Urriza M,
    2. Pineau L,
    3. Capdepuy M,
    4. Roques C,
    5. Caumette P,
    6. Quentin C
    . 2000. Antimicrobial resistance of mesophilic Aeromonas spp. isolated from two European rivers. J Antimicrob Chemother46:297–301. doi:10.1093/jac/46.2.297.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Dobiasova H,
    2. Kutilova I,
    3. Piackova V,
    4. Vesely T,
    5. Cizek A,
    6. Dolejska M
    . 2014. Ornamental fish as a source of plasmid-mediated quinolone resistance genes and antibiotic resistance plasmids. Vet Microbiol171:413–421. doi:10.1016/j.vetmic.2014.02.011.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Shakir Z,
    2. Khan S,
    3. Sung K,
    4. Khare S,
    5. Khan A,
    6. Steele R,
    7. Nawaz M
    . 2012. Molecular characterization of fluoroquinolone-resistant Aeromonas spp. isolated from imported shrimp. Appl Environ Microbiol78:8137–8141. doi:10.1128/AEM.02081-12.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Arias A,
    2. Seral C,
    3. Gude MJ,
    4. Castillo FJ
    . 2010. Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria. Int Microbiol13:135–141. doi:10.2436/20.1501.01.118.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Alcaide E,
    2. Blasco MD,
    3. Esteve C
    . 2010. Mechanisms of quinolone resistance in Aeromonas species isolated from humans, water and eels. Res Microbiol161:40–45. doi:10.1016/j.resmic.2009.10.006.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Sinha S,
    2. Chattopadhyay S,
    3. Bhattacharya SK,
    4. Nair GB,
    5. Ramamurthy T
    . 2004. An unusually high level of quinolone resistance associated with type II topoisomerase mutations in quinolone resistance-determining regions of Aeromonas caviae isolated from diarrhoeal patients. Res Microbiol155:827–829. doi:10.1016/j.resmic.2004.06.008.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Giraud E,
    2. Blanc G,
    3. Bouju-Albert A,
    4. Weill FX,
    5. Donnay-Moreno C
    . 2004. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. J Med Microbiol53:895–901. doi:10.1099/jmm.0.45579-0.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Hernould M,
    2. Gagné S,
    3. Fournier M,
    4. Quentin C,
    5. Arpin C
    . 2008. Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance. Antimicrob Agents Chemother52:1559–1563. doi:10.1128/AAC.01052-07.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Figueira V,
    2. Vaz-Moreira I,
    3. Silva M,
    4. Manaia CM
    . 2011. Diversity and antibiotic resistance of Aeromonas spp. in drinking and waste water treatment plants. Water Res45:5599–5611. doi:10.1016/j.watres.2011.08.021.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Cattoir V,
    2. Poirel L,
    3. Aubert C,
    4. Soussy CJ,
    5. Nordmann P
    . 2008. Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg Infect Dis14:231–237. doi:10.3201/eid1402.070677.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Han JE,
    2. Kim JH,
    3. Choresca CH Jr.,
    4. Shin SP,
    5. Jun JW,
    6. Chai JY,
    7. Park SC
    . 2012. First description of ColE-type plasmid in Aeromonas spp. carrying quinolone resistance (qnrS2) gene. Lett Appl Microbiol55:290–294. doi:10.1111/j.1472-765X.2012.03293.x.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Dobiasova H,
    2. Videnska P,
    3. Dolejska M
    . 2015. Complete sequences of IncU plasmids harboring quinolone resistance genes qnrS2 and aac(6′)-Ib-cr in Aeromonas spp. from ornamental fish. Antimicrob Agents Chemother60:653–657. doi:10.1128/AAC.01773-15.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Picão RC,
    2. Poirel L,
    3. Demarta A,
    4. Silva CS,
    5. Corvaglia AR,
    6. Petrini O,
    7. Nordmann P
    . 2008. Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake. J Antimicrob Chemother62:948–950. doi:10.1093/jac/dkn341.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Marti E,
    2. Balcázar JL
    . 2012. Multidrug resistance-encoding plasmid from Aeromonas sp. strain P2G1. Clin Microbiol Infect18:E366–E368. doi:10.1111/j.1469-0691.2012.03935.x.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Parshikov IA,
    2. Freeman JP,
    3. Lay JO Jr.,
    4. Beger RD,
    5. Williams AJ,
    6. Sutherland JB
    . 1999. Regioselective transformation of ciprofloxacin to N-acetylciprofloxacin by the fungus Mucor ramannianus. FEMS Microbiol Lett177:131–135. doi:10.1111/j.1574-6968.1999.tb13723.x.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Schumacher A,
    2. Steinke P,
    3. Bohnert JA,
    4. Akova M,
    5. Jonas D,
    6. Kern WV
    . 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother57:344–348. doi:10.1093/jac/dki446.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Kern WV,
    2. Steinke P,
    3. Schumacher A,
    4. Schuster S,
    5. von Baum H,
    6. Bohnert JA
    . 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J Antimicrob Chemother57:339–343. doi:10.1093/jac/dki445.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Piotrowska M,
    2. Popowska M
    . 2015. Insight into the mobilome of Aeromonas strains. Front Microbiol6:494. doi:10.3389/fmicb.2015.00494.
    OpenUrlCrossRef
  33. 33.↵
    1. Delihas N
    . 2011. Impact of small repeat sequences on bacterial genome evolution. Genome Biol Evol3:959–973. doi:10.1093/gbe/evr077.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Delihas N
    . 2008. Small mobile sequences in bacteria display diverse structure/function motifs. Mol Microbiol67:475–481. doi:10.1111/j.1365-2958.2007.06068.x.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Siguier P,
    2. Gourbeyre E,
    3. Chandler M
    . 2014. Bacterial insertion sequences: their genomic impact and diversity. FEMS Microbiol Rev38:865–891. doi:10.1111/1574-6976.12067.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    1. Bönemann G,
    2. Stiens M,
    3. Pühler A,
    4. Schlüter A
    . 2006. Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant. Antimicrob Agents Chemother50:3075–3080. doi:10.1128/AAC.00378-06.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Kohanski MA,
    2. Dwyer DJ,
    3. Hayete B,
    4. Lawrence CA,
    5. Collins JJ
    . 2007. A common mechanism of cellular death induced by bactericidal antibiotics. Cell130:797–810. doi:10.1016/j.cell.2007.06.049.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    1. Sitjes J,
    2. Ysern P,
    3. Barbe J,
    4. Llagostera M
    . 1992. Induction of ribonucleoside diphosphate reductase gene transcription by chemicals in Escherichia coli. Mutagenesis7:47–49. doi:10.1093/mutage/7.1.47.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Courcelle J,
    2. Khodursky A,
    3. Peter B,
    4. Brown PO,
    5. Hanawalt PC
    . 2001. Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli. Genetics158:41–64.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Wang M,
    2. Jacoby GA,
    3. Mills DM,
    4. Hooper DC
    . 2009. SOS regulation of qnrB expression. Antimicrob Agents Chemother53:821–823. doi:10.1128/AAC.00132-08.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Okumura R,
    2. Liao CH,
    3. Gavin M,
    4. Jacoby GA,
    5. Hooper DC
    . 2011. Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob Agents Chemother55:5942–5945. doi:10.1128/AAC.05142-11.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Kwak YG,
    2. Jacoby GA,
    3. Hooper DC
    . 2013. Induction of plasmid-carried qnrS1 in Escherichia coli by naturally occurring quinolones and quorum-sensing signal molecules. Antimicrob Agents Chemother57:4031–4034. doi:10.1128/AAC.00337-13.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Seshadri R,
    2. Joseph SW,
    3. Chopra AK,
    4. Sha J,
    5. Shaw J,
    6. Graf J,
    7. Haft D,
    8. Wu M,
    9. Ren Q,
    10. Rosovitz MJ,
    11. Madupu R,
    12. Tallon L,
    13. Kim M,
    14. Jin S,
    15. Vuong H,
    16. Stine OC,
    17. Ali A,
    18. Horneman AJ,
    19. Heidelberg JF
    . 2006. Genome sequence of Aeromonas hydrophila ATCC 7966T: jack of all trades. J Bacteriol188:8272–8282. doi:10.1128/JB.00621-06.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Del Castillo CS,
    2. Hikima J,
    3. Jang HB,
    4. Nho SW,
    5. Jung TS,
    6. Wongtavatchai J,
    7. Kondo H,
    8. Hirono I,
    9. Takeyama H,
    10. Aoki T
    . 2013. Comparative sequence analysis of a multidrug-resistant plasmid from Aeromonas hydrophila. Antimicrob Agents Chemother57:120–129. doi:10.1128/AAC.01239-12.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Poirel L,
    2. Carrër A,
    3. Pitout JD,
    4. Nordmann P
    . 2009. Integron mobilization unit as a source of mobility of antibiotic resistance genes. Antimicrob Agents Chemother53:2492–2498. doi:10.1128/AAC.00033-09.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Gillings MR,
    2. Labbate M,
    3. Sajjad A,
    4. Giguère NJ,
    5. Holley MP,
    6. Stokes HW
    . 2009. Mobilization of a Tn402-like class 1 integron with a novel cassette array via flanking miniature inverted-repeat transposable element-like structures. Appl Environ Microbiol75:6002–6004. doi:10.1128/AEM.01033-09.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Zong Z
    . 2014. The complex genetic context of blaPER-1 flanked by miniature inverted-repeat transposable elements in Acinetobacter johnsonii. PLoS One9:e90046. doi:10.1371/journal.pone.0090046.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Marti E,
    2. Huerta B,
    3. Rodríguez-Mozaz S,
    4. Barceló D,
    5. Jofre J,
    6. Balcázar JL
    . 2014. Characterization of ciprofloxacin-resistant isolates from a wastewater treatment plant and its receiving river. Water Res61:67–76. doi:10.1016/j.watres.2014.05.006.
    OpenUrlCrossRef
  49. 49.↵
    1. Flach CF,
    2. Johnning A,
    3. Nilsson I,
    4. Smalla K,
    5. Kristiansson E,
    6. Larsson DG
    . 2015. Isolation of novel IncA/C and IncN fluoroquinolone resistance plasmids from an antibiotic-polluted lake. J Antimicrob Chemother70:2709–2717. doi:10.1093/jac/dkv167.
    OpenUrlCrossRefPubMed
  50. 50.↵
    1. Kim OS,
    2. Cho YJ,
    3. Lee K,
    4. Yoon SH,
    5. Kim M,
    6. Na H,
    7. Park SC,
    8. Jeon YS,
    9. Lee JH,
    10. Yi H,
    11. Won S,
    12. Chun J
    . 2012. Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol62:716–721. doi:10.1099/ijs.0.038075-0.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Wiegand I,
    2. Hilpert K,
    3. Hancock RE
    . 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc3:163–175. doi:10.1038/nprot.2007.521.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    1. Liao X,
    2. Fang L,
    3. Li L,
    4. Sun J,
    5. Li X,
    6. Chen M,
    7. Deng H,
    8. Yang Q,
    9. Li X,
    10. Liu Y
    . 2015. Characterization of chromosomal qnrB and ampC alleles in Citrobacter freundii isolates from different origins. Infect Genet Evol35:214–220. doi:10.1016/j.meegid.2015.07.011.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Liu BT,
    2. Wang XM,
    3. Liao XP,
    4. Sun J,
    5. Zhu HQ,
    6. Chen XY,
    7. Liu YH
    . 2011. Plasmid-mediated quinolone resistance determinants oqxAB and aac(6′)-Ib-cr and extended-spectrum beta-lactamase gene blaCTX-M-24 co-located on the same plasmid in one Escherichia coli strain from China. J Antimicrob Chemother66:1638–1639. doi:10.1093/jac/dkr172.
    OpenUrlCrossRefPubMed
  54. 54.↵
    1. Park CH,
    2. Robicsek A,
    3. Jacoby GA,
    4. Sahm D,
    5. Hooper DC
    . 2006. Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother50:3953–3955. doi:10.1128/AAC.00915-06.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Cohen SN,
    2. Chang AC,
    3. Hsu L
    . 1972. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A69:2110–2114. doi:10.1073/pnas.69.8.2110.
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Datsenko KA,
    2. Wanner BL
    . 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A97:6640–6645. doi:10.1073/pnas.120163297.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    1. Sambrook J,
    2. Russell DW
    . 2006. Preparation of plasmid DNA by alkaline lysis with SDS: maxipreparation. CSH Protoc 2006:pdb.prot4090. doi:10.1101/pdb.prot4090.
    OpenUrlFREE Full Text
  58. 58.↵
    1. Delcher AL,
    2. Bratke KA,
    3. Powers EC,
    4. Salzberg SL
    . 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics23:673–679. doi:10.1093/bioinformatics/btm009.
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Overbeek R,
    2. Begley T,
    3. Butler RM,
    4. Choudhuri JV,
    5. Chuang HY,
    6. Cohoon M,
    7. de Crécy-Lagard V,
    8. Diaz N,
    9. Disz T,
    10. Edwards R,
    11. Fonstein M,
    12. Frank ED,
    13. Gerdes S,
    14. Glass EM,
    15. Goesmann A,
    16. Hanson A,
    17. Iwata-Reuyl D,
    18. Jensen R,
    19. Jamshidi N,
    20. Krause L,
    21. Kubal M,
    22. Larsen N,
    23. Linke B,
    24. McHardy AC,
    25. Meyer F,
    26. Neuweger H,
    27. Olsen G,
    28. Olson R,
    29. Osterman A,
    30. Portnoy V,
    31. Pusch GD,
    32. Rodionov DA,
    33. Rückert C,
    34. Steiner J,
    35. Stevens R,
    36. Thiele I,
    37. Vassieva O,
    38. Ye Y,
    39. Zagnitko O,
    40. Vonstein V
    . 2005. The subsystems approach to genome annotation and its use in the project to annotate 1000 genomes. Nucleic Acids Res33:5691–5702. doi:10.1093/nar/gki866.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Yu C,
    2. Zavaljevski N,
    3. Desai V,
    4. Reifman J
    . 2009. Genome-wide enzyme annotation with precision control: catalytic families (CatFam) databases. Proteins74:449–460. doi:10.1002/prot.22167.
    OpenUrlCrossRefPubMedWeb of Science
  61. 61.↵
    1. Pruitt KD,
    2. Tatusova T,
    3. Klimke W,
    4. Maglott DR
    . 2009. NCBI reference sequences: current status, policy and new initiatives. Nucleic Acids Res37:D32–D36. doi:10.1093/nar/gkn721.
    OpenUrlCrossRefPubMedWeb of Science
  62. 62.↵
    1. Tatusov RL,
    2. Galperin MY,
    3. Natale DA,
    4. Koonin EV
    . 2000. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res28:33–36. doi:10.1093/nar/28.1.33.
    OpenUrlCrossRefPubMedWeb of Science
  63. 63.↵
    1. Gatlin CL,
    2. Kleemann GR,
    3. Hays LG,
    4. Link AJ,
    5. Yates JR III
    . 1998. Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem263:93–101. doi:10.1006/abio.1998.2809.
    OpenUrlCrossRefPubMedWeb of Science
  64. 64.↵
    1. Eng JK,
    2. McCormack AL,
    3. Yates JR
    . 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom5:976–989. doi:10.1016/1044-0305(94)80016-2.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes
Dae-Wi Kim, Cung Nawl Thawng, Sang Hee Lee, Chang-Jun Cha
mSphere May 2017, 2 (3) e00203-17; DOI: 10.1128/mSphere.00203-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print
Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mSphere article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes
(Your Name) has forwarded a page to you from mSphere
(Your Name) thought you would be interested in this article in mSphere.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Unique Features of Aeromonas Plasmid pAC3 and Expression of the Plasmid-Mediated Quinolone Resistance Genes
Dae-Wi Kim, Cung Nawl Thawng, Sang Hee Lee, Chang-Jun Cha
mSphere May 2017, 2 (3) e00203-17; DOI: 10.1128/mSphere.00203-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Aeromonas
plasmid-mediated quinolone resistance
aac(6')-Ib-cr
miniature inverted-repeat transposable element
qnrS2
regulator of sigma D

Related Articles

Cited By...

About

  • About mSphere
  • Board of Editors
  • Policies
  • For Reviewers
  • For the Media
  • Embargo Policy
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Types of Articles
  • Getting Started
  • Ethics
  • Contact Us

Follow #mSphereJ

@ASMicrobiology

       

 

Website feedback

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2379-5042